Source:http://linkedlifedata.com/resource/pubmed/id/11560207
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2001-9-18
|
pubmed:abstractText |
A pilot clinical trial to assess the efficacy of intrapartum zidovudine (ZDV) infusion alone in the reduction of maternal viral load and its potential role in preventing vertical transmission of HIV-1. Twenty six, asymptomatic antiretroviral naïve HIV-1 infected pregnant women who had no prior antenatal care and were in labor were enrolled. Each patient received ZDV infusion at the rate of 2 mg/kg within the first hour. ZDV was then continuously infused at 1 mg/kg/h until delivery. Maternal plasma HIV-1 RNA prior to the commencement of ZDV infusion and within an hour after delivery were measured. HIV-1 transmission was documented by nested polymerase chain reaction in infants at six months of age. Median maternal plasma HIV-1 RNA prior to the ZDV infusion and after delivery was 29,401 and 32,555 copies/ml respectively, (p>0.05). The estimated HIV-1 transmission rate was 19.2 per cent (95% CI = 4-34). This result suggested that in asymptomatic HIV-1 infected pregnant women who were antiretroviral naïve and had no prior antenatal care, intrapartum ZDV infusion alone failed to reduce maternal HIV-1 viremia and the transmission rate of HIV-1.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0125-2208
|
pubmed:author |
pubmed-author:ChaithongwongwatthanaSS,
pubmed-author:ChantheptaewanNN,
pubmed-author:KongsinPP,
pubmed-author:LimpongsanurakSS,
pubmed-author:PhanuphakPP,
pubmed-author:RuxrungthamKK,
pubmed-author:TarounotaiUU,
pubmed-author:ThaithumyanonPP,
pubmed-author:ThisyakornUU,
pubmed-author:TriratwerapongTT,
pubmed-author:UbolyamSS
|
pubmed:issnType |
Print
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
611-6
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:11560207-Anti-HIV Agents,
pubmed-meshheading:11560207-Female,
pubmed-meshheading:11560207-HIV Infections,
pubmed-meshheading:11560207-HIV-1,
pubmed-meshheading:11560207-Humans,
pubmed-meshheading:11560207-Infant, Newborn,
pubmed-meshheading:11560207-Infectious Disease Transmission, Vertical,
pubmed-meshheading:11560207-Infusions, Intravenous,
pubmed-meshheading:11560207-Pilot Projects,
pubmed-meshheading:11560207-Pregnancy,
pubmed-meshheading:11560207-Pregnancy Complications, Infectious,
pubmed-meshheading:11560207-Pregnancy Outcome,
pubmed-meshheading:11560207-RNA, Viral,
pubmed-meshheading:11560207-Statistics, Nonparametric,
pubmed-meshheading:11560207-Treatment Outcome,
pubmed-meshheading:11560207-Viral Load,
pubmed-meshheading:11560207-Zidovudine
|
pubmed:year |
2001
|
pubmed:articleTitle |
Intrapartum zidovudine infusion alone failed to reduce both maternal HIV-1 viral load and HIV-1 infection in infant.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Chulalongkorn University, Bangkok, Thailand.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|